Table 1.
Ubiquitin-independent degradation assays
Assay | Strengths | Weaknesses |
---|---|---|
Absence of ubiquitination | Can be a visually compelling, companion experiment. |
Ubiquitinated intermediates are short-lived and challenging to isolate, so negative results are difficult to interpret without extensive positive controls. |
Unstable in ats20 cells | Most direct and reliable assay when proper ubiquitin-dependent controls are also analyzed. |
Positive controls such as p53 only show ubiquitin- dependent degradation impairment but not necessarilya complete inhibition; Possibility that specific degradation events depend more highly on Ube 1L2 as opposed to the ts Ube 1 protein. |
Immune to bDN ubiquitin | Direct and reliable assay when proper ubiquitin- dependent controls are also analyzed. |
Transfection based assay in which it is difficult to achieve high-level inhibition even of positive controls. |
Unstable lysine-less mutant |
Simple assay for a subset of small proteins but that requires inhibitors to confirm proteasome- mediated degradation. |
Larger proteins require multiple lysine mutations that may affect overall structure; Must be conscious of N- terminal-mediated ubiquitin-dependent degradation. |
In vitro degradation | Defined assay favored by protein biochemists. | Inability to confirm that processes that can occur in vitro actually do occur In vitro; Technically demanding assay that requires all necessary reaction components (which may or may not be known). |
ts20: temperature sensitive
DN: dominant negative